Category: 10071-38-2

Application of 10071-38-2, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.10071-38-2, Name is 6-Chloro-2-methylpyridazin-3(2H)-one, molecular formula is C5H5ClN2O. In a Patent，once mentioned of 10071-38-2

DIAZEPINE AND DIAZOCANE COMPOUNDS AS MC4 AGONISTS

The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, L and n are as defined in the specification. These compounds are useful as MC4 agonists

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 10071-38-2

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N1106 – PubChem

 

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 10071-38-2, name is 6-Chloro-2-methylpyridazin-3(2H)-one, introducing its new discovery. Formula: C5H5ClN2O

HETEROCYCLIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF FACTOR XA

The invention relates to compounds of formula (I), wherein R 1 , R 2 and R 3 are independently selected from carbon and nitrogen, and where at least one of R 1 , R 2 and R 3 is nitrogen; A is a single bond or a double bond; n is 0, 1, 2 or 3; each R 4 is independently selected from hydrogen, C 1-3 alkyl, hydroxy, oxo and thioxo; R 5 is hydrogen or oxo; m is 0, 1, 2 or 3; each R 6 is independently selected from hydrogen, C 1-5 alkyl, oxo, carboxy, cyano, tetrazolyl, hydroxy C 1-5 alkyl, carboxy C 1-5 alkyl, C 1-5 alkylcarboxy, C 1-5 alkoxyoxo C 1-5 alkyl, carbamoyl, C 1-5 alkylcarbamoyl, di(C 1-5 alkyl) carbamoyl, -CONR 80 (CH 2 ) x S(O) p R 9 , -CONH(CH 2 ) q NR 10 R 11 , -C 1-5 alkyl-Y 1 , -COOCHR 17 R 18 and -CON R 17 R 18 ; R 7 is carbon or nitrogen; p1 is 0, 1 or 2; each R 8 is independently selected from hydrogen and halogen; or a pharmaceutically acceptable salt thereof, said compounds possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the compounds, to their use, to pharmaceutical compositions comprising them, to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect, and to combinations comprising them

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 10071-38-2, and how the biochemistry of the body works.Formula: C5H5ClN2O

Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1105 – PubChem

 

Related Products of 10071-38-2, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Patent, and a compound is mentioned, 10071-38-2, 6-Chloro-2-methylpyridazin-3(2H)-one, introducing its new discovery.

HETEROCYCLIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF FACTOR XA

The invention relates to compounds of formula (I), Chemical formula should be inserted here. Please see paper copy wherein R 1 is hydrogen, C 1-3 alkyl, R 5 R 6 aminoC 1-5 alkyl, where R 5 and R 6 are each independently selected from hydrogen and C 1-3 alkyl, or R 5 and R 6 may, together with the nitrogen to which they are attached, form a five- or six-membered heterocyclic ring, where said heterocyclic ring has 0 or 1 additional heteroatom; n is 1 or 2; each R 2 are independently selected from hydrogen, oxo and C 1-3 alkyl, R 3 is an indolyl, and R 4 a hydrogen or a halogen; or a pharmaceutically acceptable salt thereof, said compounds possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the compounds, to their use, to pharmaceutical compositions comprising them, to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect, and to combinations comprising them

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 10071-38-2. In my other articles, you can also check out more blogs about 10071-38-2

Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1109 – PubChem

 

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. Product Details of 10071-38-2. Introducing a new discovery about 10071-38-2, Name is 6-Chloro-2-methylpyridazin-3(2H)-one

2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: Design, synthesis, and SAR studies

A set of regioisomeric 2-substituted pyridazin-3(2H)-ones containing a 3-oxo-3-phenylprop-1-en-1-yl fragment at either position 4, 5 or 6 and 2-substituted pyridazin-3(2H)-ones containing the same fragment both at positions 4 and 5 have been synthesized and evaluated as antiplatelet agents. The study allows the identification of a new highly potent platelet aggregation inhibitor (4c).

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Product Details of 10071-38-2, you can also check out more blogs about10071-38-2

Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1123 – PubChem